세계의 ADME 독성 시험 시장 보고서(2025년)
ADME Toxicology Testing Global Market Report 2025
상품코드 : 1824323
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 ADME 독성 시험 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년까지 179억 8,000만 달러로 성장해 CAGR은 11.8%로 예상됩니다. 예측기간의 성장은 바이오의약품의 급속한 확대, 맞춤형 의료의 중시 증가, 첨단 요법 출현, 독성 예측 모델의 강화, 화학제품 안전성 검사의 세계적인 증가 등에 기인한다고 생각됩니다. 예측기간의 주요 동향으로는 바이오마커 용도의 확대, 멀티오믹스 데이터의 통합, in vitro 검사에 대한 규제의 중시, 공동 연구와 파트너십, 기술의 지속적인 진보 등을 들 수 있습니다.

향후 5년간의 성장률 11.8%라는 예측은 지난 예측으로부터 0.2% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 싱가포르와 핀란드에서 수입되는 자동 ADME 스크리닝 플랫폼 및 메타볼롬 시약의 비용을 증가시키고 전임상 검사를 지연시키거나 제약 기업의 연구 개발비를 상승시킬 수 있기 때문에 미국의 의약품 개발을 혼란시킬 수 있습니다. 또한 상호관세나 무역마찰 및 제한의 격화에 의한 세계 경제 및 무역에 대한 악영향에 의해 그 영향은 보다 광범위하게 미칠 것으로 예측됩니다.

신규 의약품에 대한 수요 증가는 앞으로 수년간 ADME 독성 시험 시장의 성장을 이끌 것으로 예측됩니다. 신약은 지금까지 치료 목적으로 승인되거나 상시되지 않은 의약품입니다. ADME 독성 시험는 신약이 안전하고 체내에서 유해한 독소를 생성하지 않는지 확인하기 위한 의약품 개발의 중요한 단계입니다. 예를 들어 2024년 1월 미국 식품의약국(FDA)의 한 부문인 약제평가연구센터(CDER)가 발표한 신약치료 승인 2023년 보고서에 따르면 2023년 CDER가 승인한 신약은 55품목으로, 그 중 20품목(36%)이 퍼스트 인 클래스로 분류되어 2022년에 승인되었습니다. 따라서 신약에 대한 수요 증가는 ADME 독성 시험 시장의 성장을 뒷받침하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

ADME toxicology testing comprises a series of studies aimed at evaluating the potential toxicity of a substance or drug candidate based on its absorption, distribution, metabolism, and excretion (ADME) properties. These tests play a crucial role in drug development, ensuring the safety and well-being of individuals exposed to various substances.

The primary products associated with ADME toxicology testing include instruments, software solutions, assay systems, reagents, and other related items. Instruments are specialized devices or tools designed for specific purposes, commonly utilized in scientific, medical, or technical contexts. In the context of ADME toxicity testing, instruments are used for the measurement and analysis of readings. Various methods are employed in ADME toxicology testing, including cellular assay, biochemical assay, in silico, and ex-vivo approaches. These methods are complemented by technologies such as single-cell culture, high throughput screening, molecular imaging, omics technology, and other relevant technologies. ADME toxicology testing is applied to assess systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and other factors. Industries that benefit from these tests include cosmetics and household products, pharmaceuticals, the animal industry, the food industry, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The ADME toxicology testing market research report is one of a series of new reports from The Business Research Company that provides ADME toxicology testing market statistics, including ADME toxicology testing industry global market size, regional shares, competitors with an ADME toxicology testing market share, detailed ADME toxicology testing market segments, market trends and opportunities, and any further data you may need to thrive in the ADME toxicology testing industry. This ADME toxicology testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adme toxicology testing market size has grown rapidly in recent years. It will grow from $10.4 billion in 2024 to $11.5 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to stringent regulatory requirements, rising drug development activities, growing concerns about drug safety, advancements in in vitro testing methods, increased outsourcing of toxicology studies.

The adme toxicology testing market size is expected to see rapid growth in the next few years. It will grow to $17.98 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to rapid expansion of biopharmaceuticals, growing emphasis on personalized medicine, emergence of advanced therapies, enhanced predictive toxicology models, global increase in chemical safety testing. Major trends in the forecast period include expansion of biomarker applications, integration of multi-omics data, regulatory emphasis on in vitro testing, collaborations and partnerships, continuous advancements in technology.

The forecast of 11.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. drug development by increasing costs for automated ADME screening platforms and metabolomic reagents imported from Singapore and Finland, potentially delaying preclinical trials and raising pharma R&D expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for novel drugs is anticipated to drive the growth of the ADME toxicology testing market in the coming years. Novel drugs are pharmaceutical substances that have not been previously approved or marketed for therapeutic purposes. ADME toxicity testing is a crucial phase in drug development to ensure that the novel drug is safe and does not produce harmful toxins in the body. For example, in January 2024, the New Drug Therapy Approvals 2023 report published by the Center for Drug Evaluation and Research (CDER), a U.S. Food and Drug Administration (FDA) branch, indicated that CDER approved 55 novel drugs in 2023, with 20 (36%) classified as first-in-class, compared to 37 novel drug approvals in 2022. Thus, the rising demand for novel drugs is fueling the growth of the ADME toxicology testing market.

The expanding pharmaceutical industry is expected to drive the growth of the ADME toxicology testing market in the future. The pharmaceutical industry encompasses the discovery, development, and production of drugs and medicines by both government and private entities. This sector employs ADME toxicology testing to assess the absorption, distribution, metabolism, and excretion (ADME) characteristics of drug candidates and evaluate their potential toxicity. Such testing is essential for predicting a drug's behavior within the human body, including its absorption rates, distribution to target tissues, metabolism, and elimination. For instance, in September 2024, statistics from Cross River Therapy, a U.S.-based provider of ABA therapy services, indicated that the U.S. pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medicines in 2021. Projected spending is anticipated to rise to between $605 billion and $635 billion by 2025. Therefore, the growth of the pharmaceutical industry is driving the expansion of the ADME toxicology testing market.

Technological advancements are emerging as a pivotal trend gaining traction within the ADME toxicology testing market. Major companies within this sector are actively introducing innovative assay solutions embedded with advanced technologies, aiming to fortify their market standing. An illustrative example occurred in April 2022 when Charles River Laboratories International Inc., a US-based pharmaceutical company, partnered with Valo Health Inc., a US-based AI-health solutions provider, to unveil Logica. This cutting-edge AI-based drug development solution harnesses Valo's Opal Computational Platform, utilizing AI to offer ADME toxicology testing services and other drug delivery solutions, thereby revolutionizing drug development methodologies.

Prominent entities operating within the ADME toxicology testing market are integrating advanced technologies such as Cyprotex e-Store, fostering a seamless avenue for online ordering of ADME-Tox services. ADME-Tox services serve the purpose of reducing development costs and time, mitigating the risk of failure in later stages, and facilitating the identification of optimal candidates for clinical development. For instance, in October 2023, Evotec SE, a Germany-based biotechnology company, launched the Cyprotex e-Store, an e-commerce platform designed to provide convenient online access to the company's comprehensive range of ADME-Tox services. This platform streamlines and expedites the purchasing process, enabling registered users to assess and order Cyprotex' offerings at any time, seven days a week. The e-Store grants instant access to pricing details and comprehensive protocols online, allowing users to easily place, track, and reorder services as needed. This efficient platform significantly reduces service lead times, ensuring users receive their data promptly, thus enhancing overall efficiency in ADME-Tox testing processes.

In September 2022, BioIVT, a U.S.-based provider of drug development solutions, successfully acquired XenoTech for an undisclosed amount. This strategic acquisition marks a significant milestone for BioIVT, as it not only complements and strengthens its existing product portfolio but also facilitates the expansion of its offerings into new geographical regions and a wider customer base. XenoTech, a U.S.-based contract research organization, specializes in providing ADME-toxicology testing services. The acquisition underscores BioIVT's commitment to enhancing its capabilities and presence in the field of drug development.

Major companies operating in the ADME toxicology testing market include AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systemes SE, Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited, Admecell Inc., Molecular Discovery Ltd.

North America was the largest region in the ADME toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adme toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the adme toxicology testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ADME toxicology testing market consists of revenues earned by entities by providing services such as drug discovery research, measuring gene expression, and preclinical efficacy testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The ADME toxicology testing market also includes sales of ADMET predictors, and UV spectrophotometers, which are used in providing ADME toxicology testing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

ADME Toxicology Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adme toxicology testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for adme toxicology testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The adme toxicology testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. ADME Toxicology Testing Market Characteristics

3. ADME Toxicology Testing Market Trends And Strategies

4. ADME Toxicology Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global ADME Toxicology Testing Growth Analysis And Strategic Analysis Framework

6. ADME Toxicology Testing Market Segmentation

7. ADME Toxicology Testing Market Regional And Country Analysis

8. Asia-Pacific ADME Toxicology Testing Market

9. China ADME Toxicology Testing Market

10. India ADME Toxicology Testing Market

11. Japan ADME Toxicology Testing Market

12. Australia ADME Toxicology Testing Market

13. Indonesia ADME Toxicology Testing Market

14. South Korea ADME Toxicology Testing Market

15. Western Europe ADME Toxicology Testing Market

16. UK ADME Toxicology Testing Market

17. Germany ADME Toxicology Testing Market

18. France ADME Toxicology Testing Market

19. Italy ADME Toxicology Testing Market

20. Spain ADME Toxicology Testing Market

21. Eastern Europe ADME Toxicology Testing Market

22. Russia ADME Toxicology Testing Market

23. North America ADME Toxicology Testing Market

24. USA ADME Toxicology Testing Market

25. Canada ADME Toxicology Testing Market

26. South America ADME Toxicology Testing Market

27. Brazil ADME Toxicology Testing Market

28. Middle East ADME Toxicology Testing Market

29. Africa ADME Toxicology Testing Market

30. ADME Toxicology Testing Market Competitive Landscape And Company Profiles

31. ADME Toxicology Testing Market Other Major And Innovative Companies

32. Global ADME Toxicology Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The ADME Toxicology Testing Market

34. Recent Developments In The ADME Toxicology Testing Market

35. ADME Toxicology Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기